Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 12, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Receives Notices of Allowance for Key European Patent Applications Protecting Its Cysteamine Portfolio

NOVATO, Calif., April 12, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that the European Patent Office has issued a Notice of...
March 30, 2012 11:43 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Submits New Drug Application for RP103 for the Potential Treatment of Nephropathic Cystinosis

NOVATO, Calif., March 30, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP) announced that it submitted a New Drug Application ("NDA") to the U.S. Food and...
March 28, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Announces the Appointment of Henk Doude van Troostwijk as General Manager of European Commercial Operations

NOVATO, Calif., March 28, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), announced the appointment of Henk Doude van Troostwijk as its General Manager...
March 26, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Announces EMA Validation of Marketing Authorization Application for RP103 for the Treatment of Nephropathic Cystinosis

NOVATO, Calif., March 26, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), announced that the European Medicines Agency ("EMA") has determined that...
March 02, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Upgraded to Trade on the NASDAQ Global Market

NOVATO, Calif., March 2, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP) today announced that the Company has been upgraded to trade on the NASDAQ Global...
February 10, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. to Present at Three Upcoming Investor Conferences

NOVATO, Calif., Feb. 10, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP) today announced that its Chief Executive Officer, Christopher M. Starr, Ph.D.,...
January 04, 2012 15:59 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. to Present at the 30th Annual JP Morgan Healthcare Conference

NOVATO, Calif., Jan. 4, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP) today announced that Christopher M. Starr, Ph.D., Raptor's Chief Executive...
December 21, 2011 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Provides Program Update on RP103 (DR Cysteamine) for Nephropathic Cystinosis

NOVATO, Calif., Dec. 21, 2011 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP) announced today a program update for its lead investigational compound, RP103...
December 19, 2011 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Signs Collaborative Research and Development Agreement With NIDDK on Phase 2b Clinical Trial of RP104 (DR Cysteamine Tablets) in Non-Alcoholic Steatohepatitis ("NASH")

Phase 2b Trial Anticipated to Start in Q1 2012 Company to Host NASH Event at JP Morgan Healthcare Conference NOVATO, Calif., Dec. 19, 2011 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp....
December 13, 2011 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. to Present at the Oppenheimer 22nd Annual Healthcare Conference

NOVATO, Calif., Dec. 13, 2011 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP) today announced that Christopher M. Starr, Ph.D., Raptor's Chief Executive...